Immunization With 8 Peptides Mixed With CpG 7909 or Montanide ISA51 in Patients With Metastatic Cutaneous Melanoma
Clinical trial NCT00145158 · TERMINATED
Trial details
- NCT number
- NCT00145158
- Sponsor
- Ludwig Institute for Cancer Research
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Primary completion
- 2007-11-30
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.